EAU Podcasts

Welcome to 'Episode 4' of the series “What young urologists need to know", titled "Effective time management for busy urologists: techniques and tools”, where Prof. Francesco Montorsi (IT) and Dr. Laura Mertens (NL) discuss time management tailored specifically for busy urologists.Dr. Mertens and Prof. Montorsi uncover strategies essential for optimising your workflow. They share invaluable techniques and tools to help you enhance your productivity, from mastering task prioritisation to...

In this special edition of EAU Podcasts, experts met in person at the EAU Annual Congress (EAU24) to discuss the newest updates to the EAU Guidelines on muscle-invasive and metastatic bladder cancer (MIBC). Panel chair Prof. J.A. Witjes led the conversation with co-chair Assoc. Prof. A. Van Der Heijden and panel member Prof. R. Cathomas to cover additions to the local imaging recommendations, restaging and new tools, systemic reviews to the guidelines, and combination therapies.

In this special edition of EAU Podcasts, experts Prof. Paolo Gontero and Prof. Alexandra Masson-Lecomte met in person at the EAU Annual Congress (EAU24) to discuss the newest updates to the EAU Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma (UTUC).Panel Chairs Prof. Paolo Gontero and Prof. Alexandra Masson-Lecomte cover points of change in the UTUC guidelines, including genetic testing recommendations, risk classifications, and treatment recommendations.

In 'Episode 3' of the series “What young urologists need to know", titled "Mentorship and peer support: Navigating urology together”, Prof. Prokar Dasgupta (GB) and Assoc. Prof. Juan Luis Vásquez (DK) talk about the crucial role of mentorship and peer support in the field of urology.They discuss how guidance from experienced mentors and collaboration among peers can enhance professional growth, clinical skills, and overall well-being in the challenging realm of urological practice.&nbsp...

Tune in to 'Episode 2' of the series “What young urologists need to know", titled "Academic - clinics balance: How to achieve it?", where Prof. Bhaskar Somani (GB) and Ass. Prof. Giorgio Gandaglia (IT) navigate the delicate equilibrium between academia and clinical practice in urology. In their discussion they share insightful strategies and personal experiences on balancing research commitments with patient care responsibilities. Whether you're a seasoned practitioner or an aspiring academic...

In 'Episode 1' of the series on "What young urologists need to know", segment 2 covers the topic of "Balancing the life of a young urologist". Dr. Thomas Tailly (BE) and Dr. Michiel Sedelaar (NL) offer a comprehensive exploration of the age-old question: Is it truly possible to strike a balance between work and well-being? Dr. Tailly and Dr. Sedelaar delve into the intricate interplay between work and well-being. Through their insightful discussion and evidence-based insights, you can ga...

In 'Episode 3', the final of the series on "Metastatic renal cell carcinoma", Dr. Andrea Mari (IT) talks with Dr. Chiara Ciccarese (IT) from the Medical Oncology Unit at Fondazione Policlinico Universitario A. Gemelli IRCCS, in Rome. Together they have an in-depth discussion on "Beyond first-line treatment strategies for metastatic renal cell carcinoma".Dr. Mari and Dr. Ciccarese delve into recent advancements in managing mRCC, including therapeutic options, and their impact on patient care a...

In 'Episode 2' of the series on "Metastatic renal cell carcinoma", Dr. Andrea Mari (IT) talks to Dr. Laura Marandino (GB) about "The first-line treatment strategies for metastatic renal cell carcinoma".Dr. Andrea Mari and Dr. Laura Marandino unravel the complexities of mRCC management, exploring the latest advancements, therapeutic options, and their implications for patient care. From targeted therapies to immunotherapies, they provide a comprehensive overview of the evolving treatment lands...

UROONCO PCa associate editor Dr. Constance Thibault (FR) talks to Prof. Christophe Hennequin from Saint-Louis Hospital, France about the GETUG-AFU 18 trial results he presented at ASCO GU24 in San Francisco. Prof. Hennequin shares details on the design of the study, followed by the trial results of long-term dose escalation (80 vs 70Gy) combined with long-term androgen deprivation in high-risk prostate cancer. For more details on this study, you can read this abstract on the UROONCO Pro...

In 'Episode 1' of a series on "Metastatic renal cell carcinoma", Assist. Prof. Andrea Mari (IT) and Prof. Ketan Badani (US) discuss "The role of cytoreductive nephrectomy for metastatic renal cell carcinoma ".Assist. Prof. Andrea Mari and Prof. Ketan Badani delve into the pivotal role of cytoreductive nephrectomy in the management of metastatic renal cell carcinoma (mRCC). They talk about the rationale behind this surgical intervention, its impact on patient outcomes, and the evolving landsca...

In this podcast, UROONCO RCC chief editor Dr. Carmen Mir (ES) interviews Prof. Michael Hofman from the Peter MacCallum Cancer Centre, Australia, on the results of his study “First-in-human safety, imaging and dosimetry of [68Ga]Ga-DPI-4452, a novel CA IX-targeting peptide, in patients with clear cell renal cell carcinoma (ccRCC)”. Prof. Hofman discusses the data he presented at ASCO GU24 in San Francisco and suggests that these first-in-human findings with radiolabelled DPI-4452 are enco...

In this podcast, UROONCO RCC chief editor Dr. Carmen Mir interviews Prof. Nizar Tannir from the University of Texas, MD Anderson Cancer Center, USA, on the long-term follow-up data from the phase 3 CheckMate 214 trial: Nivolumab plus ipilimumab (NIVO+IPI) vs sunitinib (SUN) for first-line treatment of advanced renal cell carcinoma (aRCC). Prof. Tannir summarises the history and stability of the Checkmate 214 trial results over the last 8 years, before discussing the latest data from his ...

In this podcast interview live from ASCO GU24 in San Francisco, UROONCO PCa associate editor Dr. Constance Thibault (FR) talks to medical oncologist Dr. Kim Chi from the University of British Columbia, Canada, about the CONTACT-2 trial. This randomised phase 3 trial aimed to evaluate the efficacy of cabozantinib + atezolizumab vs. second novel hormonal therapy in patients with metastatic castration-resistant prostate cancer (mCRPC).Dr. Chi shares his interpretation of the study design and the...

In this podcast, UROONCO RCC chief editor Dr. Carmen Mir (ES) interviews Assoc. Prof. Pedro Barata from University Hospitals Seidman Cancer Center, USA, about the results of two adjuvant RCC studies: KEYNOTE-564; and CheckMate-914.Assoc. Prof. Barata explains the positive trial results of KEYNOTE-564, which is the first time there has been an overall survival advantage with a PD-1 inhibitor in the pure adjuvant setting in RCC. These results support adjuvant pembrolizumab as a standard of care...

In this podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) interviews medical oncologist Dr. Andrea Apolo from the National Cancer Institute, USA, on the results of the AMBASSADOR study, which she presented at ASCO GU24. Dr. Apolo shares details on the rationale of the AMBASSADOR study: An open-label, randomised, phase III trial, evaluating the efficacy and safety of pembrolizumab as an adjuvant treatment in muscle-invasive and locally advanced urothelial carcinoma (MIUC).&nbsp...

In this podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) interviews Dr. Srikala Sridhar (CA), about her abstract she recently presented at ESMO 2023, PET-MUSE: “Impact of positron emission tomography (PET) imaging on staging of muscle-invasive bladder cancer (MIBC)”.Dr. Sridhar shares details on the rationale and design of the study, as well as some interesting results.For more details on this study, you can read this abstract on the UROONCO Bladder Cancer educational platform.

In this edition, Dr. Aisling Nic an Riogh (IE), a member of the EAU Guidelines panel for Non-neurogenic female LUTS, discusses bladder outlet obstruction (BOO) in women.Dr. Nic an Riogh defines bladder outlet obstruction, its prevalence, and the various symptoms. She further explains that BOO can be divided into two main groups, anatomical (physical or mechanical), and functional (non-anatomical, non-urogenic). It is diagnosed via urodynamics, and Dr. Nic an Riogh discusses the various ...

In this podcast, UROONCO RCC board members, chief editor Dr. Carmen Mir (ES), and associate editors Dr. Riccardo Bertolo (IT) and Dr. Teele Kuusk (GB), discuss the progress made in the field of kidney cancer during 2023, and what is anticipated for 2024.Some topics discussed include the game-changing ZIRCON trial, OpeRa trial, and 3D models in PN and single-port RPN, as well as SBRT – FASTRACK II. Adjuvant IO, first-line mRCC treatments (KEYNOTE-426), and RN is also reviewed.The main WH...

In 'Episode 4' of the series "What do young urologists need to know," 'Segment 1' covers the topic of "Navigating the transition from residency to professional urology practice." Assoc. Prof. Emre Şener (TR) discusses networking and building professional relationships in urology with Dr. Amelia Pietropaolo (GB).Assoc. Prof. Şener and Dr. Pietropaolo delve into the critical aspects of establishing robust connections within the urology field. They emphasise the significance of networking for yo...

This is 'Episode 3' of the podcast series "What do young urologists need to know," 'Segment 1': "Navigating the transition from residency to professional urology practice." Dr. Elena Seguí-Moya (GB) converses with Prof. Sabine Brookman-May (US) about preparing for a job interview.The discussion highlights essential steps and strategies for excelling in a job interview within the specialised field of urology, emphasising the importance of showcasing clinical skills or research experience. Addi...

In 'Episode 2' of the series on "What young urologists need to know," segment 1 covers the topic of "Navigating the transition from residency to professional urology practice." Dr. Bhavan Prasad Rai (GB) and Dr. Guido Kamphuis (NL) delve into the aspects of preparing and maintaining an effective CV. Dr. Rai and Dr. Kamphuis talk about how your CV should highlight relevant experiences and achievements, exploring the key elements that make a standout CV in the competitive field of urology. They...

In 'Episode 1' of the series on "What young urologists need to know," segment 1 covers the topic of "Navigating the transition from residency to professional urology practice." Assoc. Prof. Veeru Kasivisvanathan (GB) and Ms. María Pilar Moreno-Fontela (ES) discuss the significant transition from residency to independent practice in this episode titled: "My residency is finished: how will my life change?" Assoc. Prof. Kasivisvanathan and Ms. Moreno-Fontela delve into the challenges and adjustm...

In this podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talks with Prof. James Catto (GB) about the THOR-2 cohort 1 study: Results of erdafitinib (ERDA) vs intravesical chemotherapy (chemo) in patients with high-risk non-muscle-invasive bladder cancer (NMIBC) with select fibroblast growth factor receptor alterations (FGFRALT) who received prior bacillus calmette-guérin (BCG) treatment. Prof. Catto shares details on the rationale and design of the THOR-2 cohort 1 study, the results...

In this podcast, Dr. Neeraj Agarwal (US), presidential endowed chair of cancer research at the Huntsman Cancer Institute, University of Utah, shares the results of the LITESPARK-013 Phase 2 trial - "Safety and efficacy of two doses of belzutifan in patients with advanced renal cell carcinoma", that he presented at ESMO 2023. Firstly, Dr. Agarwal shares the rationale of the study, which compared belzutifan 200mg and 120mg doses in patients with advanced clear cell RCC that progressed on a...

In this podcast, UROONCO RCC associate editor Dr. Teele Kuusk (GB) talks with Prof. Roberto Iacovelli (IT), Gostino Gemelli University Polyclinic, Rome, about the abstract he presented at ESMO 2023, "The TIDE-A study: Phase II study of avelumab (Ave) plus intermittent axitinib in previously untreated patients with metastatic renal cell carcinoma". Prof. Iacovelli shares details on the TIDE-A study, the first study demonstrating the potential benefits of VEGFR-TKI interruption combined w...

In this podcast, UROONCO RCC associate editor Dr. Teele Kuusk (GB) talks with medical oncologist Prof. Laurence Albiges (FR), Head of the Department of Oncology at Gustave Roussy, about her abstract: Belzutifan versus everolimus in participants with previously treated advanced clear cell renal cell carcinoma (ccRCC): Randomised open-label phase III LITESPARK-005 study.Prof. Albiges discusses the study results she presented at ESMO 2023. LITESPARK-005 established HIF-2a inhibition as a novel t...

In this podcast from ESMO 2023, UROONCO BCa associate editor Dr. Laura Mertens (NL) talks with Dr. Michiel Van Der Heijden (NL) on his abstract “Nivolumab plus gemcitabine-cisplatin versus gemcitabine-cisplatin alone for previously untreated unresectable or metastatic urothelial carcinoma: results from the phase 3 CheckMate 901 trial”. Dr. Van Der Heijden shares details on the design of the trial and the late-breaking results that he presented at ESMO 2023. Primary endpoints were met with ove...

In this special podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talks with Prof. Thomas Powles (GB) about the positive results of the EV-302/KEYNOTE-A39 trial that were announced at ESMO 2023. Prof. Powles shares details on the rationale and design of the EV-302/KEYNOTE-A39 study: an open-label, randomised, controlled, phase 3 study evaluating enfortumab vedotin in combination with pembrolizumab (EV+P) versus chemotherapy in patients with previously untreated locally advanced...

In 'Episode 4' of the special podcast series on "Uro-oncologic surgery driven by new technologies", Prof. Ricardo Autorino (IT) talks to expert Assoc. Prof. Giovanni Enrico Cacciamani (US) about Artificial intelligence application for urologic cancer detection and classification.Artificial Intelligence (AI) has revolutionised urologic cancer detection by leveraging principles from computer science, machine learning and deep learning. In this context, AI serves as a powerful tool to improve th...

In 'Episode 3' of the podcast series on "Uro-oncologic surgery driven by new technologies", Prof. Ricardo Autorino (IT) talks to expert Dr. Inés Rivero Belenchón (ES) about 3D models for kidney cancer with caval thrombous.3D models are proving invaluable in addressing kidney cancer cases involving caval thrombosis, where the tumour extends into the vena cava. Dr. Rivero Belenchón discusses how these models, generated from advanced imaging, offer precise visualisations of the tumour's position...

In this podcast, UROONCO PCa associate editor Dr. Giancarlo Marra (IT) talks to Prof. Hashim Ahmed (GB) after his presentation at UROonco23 on focal therapy for low- or intermediate-risk prostate cancer. They discuss the main reasons for the change in the new guidelines this year. Prof. Ahmed details the dangers of rapid dissemination. He also shares his expert opinion on how he positions focal therapy within the context of the PROTECT trial results. He concludes with information on othe...

In 'Episode 2' of this special podcast series on "Uro-oncologic surgery driven by new technologies", Prof. Ricardo Autorino (IT) talks to expert Ass. Prof. Daniele Amparore (IT) about vascular perfusion 3D models and augmented reality for kidney cancer surgery. Vascular perfusion 3D models and augmented reality (AR) are revolutionising kidney cancer surgery. These technologies provide surgeons with detailed 3D representations of patients' kidneys and their blood vessels. By incorporating...

In this podcast, UROONCO RCC associate editor Dr. Riccardo Bertolo (IT) interviews a recognised world leader in the research and treatment of kidney cancer, Prof. Ketan Badani (US), from Mount Sinai Hospital. He answers questions on robot-assisted partial nephrectomy (RAPN) after his live surgery session at ERUS23 in Florence, Italy. Prof. Badani elaborates on the concept of complexity in RAPN.Another point in the discussion is the decision algorithm in counselling the patient to m...

This is 'Episode 1' of a new podcast series on "Uro-oncologic surgery driven by new technologies." Prof. Ricardo Autorino (IT) talks to expert Dr. Enrico Checcucci (IT) about 3D models and augmented reality for prostate cancer surgery.In the realm of prostate cancer surgery, 3D models and augmented reality (AR) are emerging as transformative technologies. Surgeons are utilising 3D models generated from patient imaging data (mp-MRI in particular for prostate cancer) to create precise vis...

This is 'Episode 4' of the special podcast series on "Preoperative, intraoperative and postoperative new technological tools for urologists". Assoc. Prof. Juan Gómez Rivas (ES) talks to expert Dr. Karl-Friedrich Kowalewski (DE) on laparoscopy procedures and the emergence of advanced robotic platforms. Over the years laparoscopy has become the standard for various interventions, such as gallbladder removal, appendectomy and certain gynaecological procedures. However, recent a...

In this third episode of the special podcast series on "Preoperative, intraoperative and postoperative new technological tools for urologists", Assoc. Prof. Juan Gómez Rivas (ES) talks to Assoc. Prof. Stefano Puliatti (IT) from the University Hospital of Modena, about new technology for surgical training. Assoc. Prof. Puliatti shares details of psychologist Prof. Anthony Gallagher's development of the proficiency-based progression (PBP) methodology for surgical training, whereby me...

In this second episode of the special podcast series on "Preoperative, intraoperative and postoperative new technological tools for urologists", Assoc. Prof. Juan Gómez Rivas (ES) talks to the distinguished Prof. Dmitry Enikeev (IL) about new lasers that are shaping the future of endourology. Prof. Enikeev elaborates on how lasers work, and the different types of lasers (thulium, holmium, green light). He shares details on usage, settings and the important aspects of distance of incision...

This is 'Episode 1' of a new podcast series on "Preoperative, intraoperative and postoperative new technological tools for urologists." Assoc. Prof. Juan Gómez Rivas (ES) talks to expert Assoc. Prof. Severin Rodler (DE) about the role of telemedicine and applications for the management of cancer patients. Telemedicine and healthcare applications have revolutionised patient management by offering remote healthcare services and personalised tools for patients. Assoc. Prof. Rodler dis...

This podcast features Prof. Gernot Bonkat (CH) and Dr. Kathrin Bausch (CH) discussing the addition of a new chapter on urogenital tuberculosis to the EAU Guidelines on urological infections.They explain that the lack of knowledge among urologists about tuberculosis, particularly genital tuberculosis, was a reason for adding the new chapter. Tuberculosis is an ancient bacterial disease affecting not only the lungs but also other organs, including the urogenital tract. Diagnosis of urogeni...

In this podcast, Dr. Kristin Zimmermann (DE) and Dr. Felix Campos-Juanatey (ES) discuss a grade 4 renal trauma case in a young woman who was kicked by a horse. They talk through the decision-making process for her diagnosis, treatment and follow-up, as well as the complications encounted.Diagnostics included FAST (Focused Assessment Sonography in Trauma), and then the American Association of Surgery of Trauma classification (AAST) was applied for clinical decision-making and planning fur...

In this podcast, Dr. Paolo Capogrosso and Dr. Marco Falcone talk about the new chapter in the sexual and reproductive EAU Guidelines on penile abnormalities and penis dysmorphophobia. With an increase in surgery requests, Dr. Capogrosso and Dr. Falcone talk about the lack of evidence in this field of urology, hence most surgical procedures for penile girth or length enhancement are experimental and should be approached with caution. The aim of the new guidelines is to provide evidence-ba...

In this roundtable discussion, Prof. Florian Wagenlehner, Dr. Zafer Tandoğdu, and Dr. Anne Ackerman talk about the challenges of infections in urology, specifically related to antimicrobial resistance. Factors such as ageing population and over-medicalisation are identified as possible causes of the increase in mortality rates for urosepsis and other antimicrobial-resistant infections.The importance of appropriate microbiological workup and non-antibiotic treatments to better support pat...

In this podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talks to Dr. Arlene O. Siefker-Radtke (US) from the Depart. of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston. She answers questions about the recent ASCO23 presentations on metastatic urothelial cancer (mUC), where new results of the phase II Norse study, and the phase III THOR study were shared.Phase II Norse study:Dr. Siefker-Radtke elaborates on the study rational and pleasing r...

In this podcast, Prof. Igor Tsaur (DE), chief editor of the UROONCO PCa editorial board talks with Dr. Craig Jones (GB), from Salford Royal and Christie Hospitals, about his recent presentation at AUA2023, "Clinical fracture incidence in metastatic hormone-sensitive prostate cancer (mHSPC) and risk-reduction following addition of zoledronic acid to androgen deprivation therapy (ADT) with or without docetaxel (Doc): Long-term results of two phase 3 trials from the STAMPEDE platform proto...

In this podcast, Prof. Igor Tsaur (DE), chief editor of the UROONCO PCa editorial board talks with Dr. Antony Pellegrino (IT) about his recent presentation at AUA 2023 on positive surgical margins. The impact of multiparametric MRI on surgical approach during radical prostatectomy (RP) and on oncological outcomes after surgery is still controversial.Dr. Pellegrino discusses the results of the topographic single centre study to predict the site of positive surgical margins (PSM) based on the s...

In this podcast, Dr. Riccardo Bertolo (IT), associate editor of the UROONCO kidney cancer editorial board talks to Prof. Jihad Kaouk (US) from the Glickman Urological and Kidney Institute, Cleveland Ohio. Prof. Kaouk answers questions about his recent AUA2023 presentation, "Single port robotic urologic surgery: where are we today and where are we headed?"The discussion includes details on the pioneering of new technologies, specifically the novel single-port robotic platform. Prof. Kaouk talk...

In this podcast, Prof. Igor Tsaur (DE), chief editor of the UROONCO PCa editorial board talks with Dr. Marcio Covas Moschovas (US) about his abstract presentation at AUA2023, “Simultaneous hernia repair following robotic-assisted radical prostatectomy is safe with low rates of mesh-related complications”. Dr. Moschovas answers questions about the study design and the data presented. He compared 244 patients who underwent RARP with concomitant hernia repair (inguinal, umbilical, and ventr...

In this podcast, Dr. Maria Carmen Mir Maresma (ES), chief editor of the UROONCO RCC editorial board talks to key opinion leader Prof. Alexander Kutikov (US) from Fox Chase Cancer Centre, Philadelphia. Prof. Kutikov shares details from his recent AUA2023 presentation in Chicago on the surgical complications associated with robotic partial nephrectomy (RPN).He discusses the four major categories of complications of RPN which include vascular complications (haemorrhage, renal AV fistula/ren...

In this podcast, UROONCO BCa chief editor Dr. Benjamin Pradere (FR) talks to Prof. Siamak Daneshmand (US) from the Keck School of Medicine, University of Southern California. Prof. Daneshmand answers questions about the SunRISe-1 trial, which he presented at the 'late-breaking oncology abstract session' during AUA2023. He discusses the study design, and delivers preliminary results from SunRISe-1 in patients with BCG (Bacillus Calmette-Guérin) unresponsive high-risk non–muscle-invasive b...

In this podcast Prof. Nicolas Mottet and Prof. Phil Cornford discuss the 2023 EAU Guidelines for prostate cancer. The new recommendation is to investigate early detection of prostate cancer as part of the EU's new cancer strategy. They talk about active surveillance for low-risk prostate cancer patients to avoid over-treatment, as well as the PSMA staging process for high-risk disease, and a caution on altering treatment without sufficient evidence. The importance of standardised MRI pro...

In this podcast, the new EAU ASCO Guidelines on penile cancer is discussed. The new guidelines are a total revision of prior versions and emphasises the importance of patient representatives and early palliative care. The panel collaborated with ASCO and integrated expertise from around the world. This expert panel talk about diagnosis and staging, with emphasis on HPV testing and minimally invasive approaches to lymph nodes. Also, treatment of the primary tumour, with recommendations fo...

In this episode, Prof. Evanguelos Xylinas (FR), a fellow of the European Board of Urology, and Prof. Fredrik Liedberg (SE) from Skåne University Hospital Malmö, share and review two difficult and exceptional bladder cancer cases. In an interactive discussion, Prof. Xylinas and Prof. Liedberg go into detail on the treatment options, guidelines and complications. This activity is supported by an educational grant with no involvement in the programme or speaker selection. Acknowledgement &...

In this episode, Dr. Hanny Cobussen-Boekhorst, a nurse practitioner (NP) and a member of the EAU guidelines panel for Female Lower Urinary Tract Symptoms (LUTS), discusses her motivation and contribution to the guidelines panel.Multidisciplinary collaboration is the future, and as a nurse, Dr. Cobussen-Boekhorst talks about the benefits of having a nurse-specialist involved in female LUTS management. Nurses have experience and expertise in providing a patient-centred approach, with a focus on...

In this podcast, Prof. Bhaskar Somani (GB), an associate of the EULIS - Working Group on ureteroscopic management of stones, and Mr. Patrick Jones (NO), a member of the EAU Young Academic Urology urolithiasis group, discuss the challenges of urolithiasis in pregnancy.The management of kidney stones during pregnancy can be challenging for most urologists in terms of using the right diagnostics and treatment, to ensure the best outcomes for the patient and the foetus. A multidisciplinary...

Dr. Felix Campos-Juanatey (ES), a member of the EAU Guidelines Panel for Urethral Strictures, answers questions on the diagnosis of urethral strictures and follow-up after urethral surgery. This podcast begins with details on what patient information is necessary to collect during an in-depth clinical interview and examination to make an accurate diagnosis. Dr. Campos-Juanatey shares the latest guidelines on when and how to conduct regular follow-up with patients after urethral str...

In this edition, Dr. Margarida Manso (PT), associate member of the EAU Section of Female and Functional Urology (ESFFU), discusses female stress urinary incontinence (SUI). Dr. Manso details the physiological elements of SUI in regards to the bladder neck and urethra, as well as the urinary sphincter. The multiple causes behind SUI are outlined, including: ageing, radiotherapy trauma and neurological disease. Dr. Manso shares information on the different treatment options...

In this edition, Dr. Lazaros Tzelves (GR), a member of the EAU Guidelines Panel for non-neurogenic female LUTS, discusses underactive bladder (UAB) in women. Dr. Tzelves clinically defines what an underactive bladder is, followed by sharing information on its prevalence and aetiology. UAB is difficult to diagnose and difficult to manage. Dr Tzelves discusses how urologists can diagnostically approach patients with suspected underactive bladder and what the options are for managing ...

In this podcast, EAU Prostate Cancer Guidelines Panel members Prof. Nicolas Mottet (FR) and Prof. Philip Cornford (GB), have an in-depth discussion on active surveillance in prostate cancer. The two experts elaborate in detail on what active surveillance is, including the difference between active surveillance and watchful waiting, which can often be mis-understood. Prof. Mottet and Prof. Cornford delve into the importance of maintaining quality of life and the fact that active sur...

In this edition, we have Dr. Maria Carmen Mir (ES), chief editor of the UROONCO RCC editorial board, together with Prof. Alessandro Antonelli (IT) from the University of Verona and director of the Department of Urology at Borgo Trento Hospital, talking about the retroperitoneal approach to robotic partial nephrectomy (RPN).Prof. Antonelli begins this interview with a review on transrectal and transperineal for retroperitoneal partial nephrectomy. He shares his experience and expert-know...

In this edition, we have Dr. Riccardo Bertolo (IT), the associate editor of UROONCO RCC editorial board, together with Dr. Alberto Breda (ES), Head of the Oncology Urology Unit and Kidney Transplant Surgical Team Urology Department, Fundació Puigvert, Barcelona, and chairman of ERUS and president of the ERUS22 congress, talking about the novel alternative robotic platform that was recently launched in Europe.Dr. Riccardo Bertolo and Dr. Alberto Breda share highlights on their first experience...

In this edition, Dr. Constance Thibault (FR), associate editor of the UROONCO PCa educational platform, discusses triplet therapy for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC). In the last decade, the outcome of metastatic prostate cancer has been improved by intensifying the systemic therapy with the addition of docetaxel and/or new hormonal therapies. Clinicians now have several treatment options to offer their patients with mHSPC. This raises the issue of t...

During this episode, Dr. Thomas Seisen (FR), an associate member on the EAU Guidelines Panel for Non-Muscle Invasive Bladder Cancer, answers questions about metastatic upper urothelial cancer (UTUC) treatment options in the 2022 guidelines:What are the systemic treatment options for metastatic UTUC in the first-line setting?Can a maintenance systemic treatment be proposed to metastatic UTUC patients responding to first-line platinum-based chemotherapy?What are the systemic treatment opt...

In this edition, we have Dr. Teele Kuusk (UK), the associate editor of the UROONCO RCC educational platform discussing kidney cancer highlights at the recent ESMO2022. Dr. Kuusk begins with the reporting of several new trials and the accompanying results, which include: Phase 3 CheckMate-914, Phase 3 COSMIC-313, Phase 2 Keynote-B61, and Cohort 1 of LITESPARK-003 study. After delivering the trial results, Dr. Kuusk shares the possible reasons why the adjuvant trials failed. For more details on...

In this podcast, members of the EAU Guidelines Panel for RCC Prof. Axel Bex (DE) and Prof. Jens Bedke (DE), discuss renal cell carcinoma (RCC), with updates on treatments and current trials. Prof. Bex and Prof. Bedke talk about what's new in adjuvant treatment for patients with high-risk RCC after radical nephrectomy. This follows with discussions on the combination and triplet trials, as well as the recent developments in the systemic treatment of advanced RCC.Other topics i...

In this edition we have Dr. Benoît Peyronnet (FR), a Panel Member, and Dr. Néha Sihra (UK), an associate member of the EAU Guidelines Panel for female lower urinary tract symptoms, discussing overactive bladder syndrome (OAB) in women. Ms. Sihra answers questions about what to do when evaluating an overactive bladder patient. She covers the importance of clinical history, and which type of examinations to do, as well as giving details on bladder diaries and symptom scores. More deta...

In this podcast, EAU Guidelines office member, Prof. Philip Cornford (GB), and Prostate Cancer Panel patient representative, Dr. Erik Briers (BE), share their views on the importance of patient input in authoring the EAU Guidelines.Our discussants review the relationship between specialists and their patients, and how they can create better advocacy, as well as, increased involvement going forward in writing the guidelines.

In this edition, Prof. Christian Radmayr talks about the importance of the dissemination of the EAU Guidelines. Prof. Christian Radmayr is a member of the Paediatric Urology Guidelines Panel and chair of this panel since 2018. In this episode he touches on the various platforms through which the EAU Guidelines are disseminated, which initatives have the most impact and how clear communication of medical guidelines is vital in the current digital climate.

In this podcast, Prof. Peter Gilling (NZ), Professor of Surgery at the University of Auckland, shares details with us on the main findings of the WATER study. Prof. Gilling gives us some insights into the five-year results of the WATER study, a pivotal trial that compares Aquablation versus transurethral resection of the prostate (TURP). The results were presented at the 2022 EAU Annual Congress. He also identifies the ideal patients for Aquablation, what steps of the procedure coul...

In this edition, we have Prof. Tamsin Greenwell (GB), a panel member on the EAU Guidelines Panel for Urethral Strictures, discussing the management of female urethral stricture disease. Prof. Greenwell begins with an overview on the causes of female urethral strictures and how a diagnosis should be made. Following this she answers questions on treatment options, including what type of urethroplasty to use (dorsal and ventral), and which tissue is best for substitution. She reports ...

In this podcast, Dr. Vasileios Sakalis (GR), a member of the EAU Guidelines Panel for Male Lower Urinary Tract Symptoms, reports on the new section in the guidelines relating to Male Urinary Incontinence.Dr Vasileios Sakalis begins with information on an important addendum to the 2022 Male LUTS Guidelines with regard to the new incontinence section, and the reasons why this new section has been included in Male LUTS. He talks about an important study that has been included in this sectio...

In this commentary, Assoc. Prof. Fardod O'Kelly (IE), member of the EAU Guidelines Panel for paediatric urology, shares his expert knowledge on nocturnal enuresis, also known as bedwetting.Assoc. Prof. O'Kelly begins by answering questions on the prevalence of bedwetting among children, teenagers and into adulthood. More details are given to define this heritable condition, as well as covering the non-genetic risk factors.Making a correct diagnosis can be challenging, and the condition is oft...

Professors Giulio Del Popolo and Gilles Karsenty (panel members), are joined by Dr. Stefania Musco (associate member) of the EAU Guidelines Panel for Neuro-urology, to talk about N-SUI.In this commentary three experts share their knowledge of neurogenic stress urinary incontinence (N-SUI); from surgical management, urodynamic evaluation, bulking agents, and other treatments, including artificial sphincter. Prof. Giu lio Del Popolo (IT) begins with an explanation to the surgical managemen...

Dr. Sajjad Rahnama'i (NL), a member of the EAU Section of Female & Functional Urology, will discuss neurogenic detrusor overactivity, including its diagnosis and treatment.Several questions will be answered. What is neurogenic detrusor overactivity, and can it be a serious condition? What is the standard diagnostic workup of a patient in whom we suspect neurogenic detrusor overactivity? What is the first line treatment of neurogenic detrusor overactivity? What are the second- and third-li...

Dr. Richard Cathomas, medical oncologist from Zurich in Switzerland discusses Immunotherapy in muscle-invasive bladder cancer.He goes into the mechanism of action of immunotherapy and why could it work well in bladder cancer. Where do we currently stand with the use of immunotherapy in the NEOADJUVANT setting of muscle invasive bladder cancer? And what is currently the best place to integrate immunotherapy for METASTATIC bladder cancer?Prof. Dr. Cathomas closes with the answer to t...

In this second edition of two updates, Professor Nicolas Mottet, the chair of the EAU Guidelines panel for prostate cancer, discusses which are the most important changes and new recommendations in the new EAU Guidelines for prostate cancer for 2022 relating to treatment approaches.

In this first edition of two updates, Professor Nicolas Mottet, the chair of the EAU Guidelines panel for prostate cancer, highlights the work of the panel.His talk includes new systematic reviews, and outlines which are the most important changes in the new EAU Guidelines for prostate cancer for 2022 relating to the definition of clinically localized and clinically significant prostate cancer, diagnostic evaluation, particularly transperineal biopsy. Professor Nicolas Mottet also discusses k...

What exactly is pain? What do I have to know about pain if I am treating patients with chronic pelvic pain? What is necessary to diagnose a chronic pelvic pain syndrome? What factors are key to successfully treat patients with a chronic pelvic pain syndrome? And what are the psychological aspects of chronic pain? Prof Daniel Engeler answers these questions.Prof Engeler is chairman of the EAU Guidelines panel on Chronic Pelvic Pain.

Dr Bela Köves answers questions about the changes in the guidelines chapter of recurrent urinary tract infections. And in particular, he elaborates on the question, what the most important updates are for the specific preventive approaches. Are there any changes regarding lifestyle advices or behavioral modifications? The second part of the podcast covers the updates about the use of topical oestrogen, immunoactive prophylaxis, the changes about prophylaxis with probiotics and cran...

In this edition, we have Professor Berk Burgu, a member of the EAU Guidelines panel for Paediatric Urology, discussing vesico-ureteral reflux in children, including its diagnosis and treatment. We get answers to the question what is vesico-ureteral reflux is and Prof. Burgu explains the importance. Should we treat vesico-ureteral reflux immediately after being diagnosed? Is there a structured diagnostic work-up for vesico-ureteral reflux? In the last part of the podcast, Prof....

In this edition, we have Dr. Toine van der Heijden discussing the three different diversions mentioned in the guideline after cystectomy - uretero cutaneostomy, ileal conduit and an orthotopic neobladder – along with the reasons for choosing a certain diversion and helping the patient to decide.Dr. Toine van der Heijden is a member of the EAU Guidelines panel for Muscle Invasive Bladder Cancer.

The new guidelines on Non-neurogenic Female LUTS have replaced the old Urinary Incontinence Guideline. Dr. Arjun Nambiar discusses the thought process behind this and tells what's new. He also goes deeper into the process that guidelines users or readers may not be aware of.Dr. Arjun Nambiar is member of the EAU Guidelines panel for non-neurogenic Female LUTS.

Dr. Sachin Malde catches up with us about the current status and future challenges in minimally invasive treatments for BPO. He elaborates on the surgical options and the EAU guidelines recommendations about the newer surgical treatments for BPO.We also gain insight into the criteria the guidelines panel use to make a recommendation about a particular treatment. And finally, Dr. Malde discuss the future developments that he think will help to strengthen the recommendations made by the EAU gui...

How can we improve the organ pool for kidney transplantation and how do we implement all alternatives in the current transplant teams? Dr. Oscar Rodriguez Faba is an associate member of the EAU Guidelines panel for kidney transplantation and talks about these questions in this podcast.Oscar Rodriguez Faba closes with the answer to the question if the results are comparable to cadaveric donors and conventional living donors.

Why bring Psychology to the management of male sexual dysfunction, which specific problems are generally approached in the psychological clinical setting and what are there emerging topics on the intersection of psychology and male sexual health are the questions that Prof. Joana Carvalho answers.Prof. Joana Carvalho is a member of the EAU Working Group on Sexual and Reproductive Health. Prof. Carvalho closes this podcast talking about the role of scientific and professional societies in...

Dr. Josine Quaedackers is a member of the EAU Guidelines panel on Paediatric Urology.In this podcast, she explains what microlithiasis is. In adults testicular microlithiasis has been associated with an increased risk of testicular malignancy. Dr. Josine Quaedackersanswered the question of whether this is the same in children.She examines the question of what happens to the risk when the child with testicular microlithiasis becomes an adult. And finally, she gave the advice in case of an inci...

Dr. Alexandra Masson-Lecomte is a member of the EAU Guidelines panel on Upper Urinary Tract Urothelial Cell Carcinoma (UTUC). In this podcast, she speaks about the challenges and evidence regarding the administration of perioperative chemotherapy in high-risk UTUC. She also discusses post-operative chemotherapy and alternatives to cisplatin based chemo.

Dr Kay Thomas is a member of the EAU Guidelines urolithiasis panel. In this podcast, she talks about the basic evaluation that should be done for all stone formers. She also elaborates on the question of who needs more specific evaluation and what investigations would you recommend. Finally, she gives her recommendations for a patient with low risk and high risks of recurrence.

Prof. Alberto Breda, the Chair of the EAU Guidelines panel for Kidney transplantation, discussing the latest advances in surgical techniques for organ retrieval and kidney transplantation surgery.

In this episode, Prof. Christian Radmayr shares his expert insights in treating undescended testes covering topics such as:Frequency of undescended testes among boysReasons for its occurrenceHow to classify undescended testesWhen to start treatmentOptions for surgical therapy, and more Guest: Prof. Christian Radmayr, the Chair of the EAU Guidelines panel for Paediatric Urology

With over 400 peer-reviewed papers published, Prof. Bhaskar Somani is an editorial board member of 4 journals and a reviewer for 15 journals. In this episode, he shares his experience in publishing scientific papers. The scope of his podcast includes:Tips and tricks for a successful outcomeHow to select a topic or a journalCore skills needed in publishing a scientific paperHow to deal with rejectionSecrets of successful teams who publish numerous articlesGuest: Prof. Bhaskar Somani, Consultan...

What are the recommendations for the management of stage I seminoma and stage I non-seminoma after orchiectomy? Tune in as Dr. Stefanie Fischer provides vital information on this, as well as, the risks of relapse after orchiectomy, and the pros and cons of various strategies. Guest: Dr Stefanie Fischer, oncologist member of the EAU Guidelines panel for Testicular Cancer

In part 2 Prof. Nicolas Mottet discusses which are the most important changes in the new EAU Guidelines for Prostate Cancer treatment related to genetic testing, M1 disease and Castration-resistant prostate cancer (CRPC). Listen also to part 1 about perineal biopsy, staging PSMA, adjuvant Radio Therapy.

Data has shown the prevalence of infertility has increased over the last decades. In this episode, Dr. Paolo Capogrosso explores if this is also the case in males. Dr. Capogrosso discusses:Any novel tests to better investigate male fertilityWhat treatment to suggest if the patient has evidence of increased DNA fragmentation and normal semen parameterUpdates on varicocele treatment, and moreGuest: Dr Paolo Capogrosso, an associate of the EAU Guidelines panel for Sexual and Reproductive Health&...

Generally speaking, while NMIBCs have a more favourable prognosis compared to their MI counterpart, they are not the same and seem to behave differently (i.e. some are relatively indolent, others have aggressive features). In this episode, Prof. Paolo Gontero explains why. He will also discuss the following:What is the current, best-recommended way for risk stratification of NMIBCsIf there is a way to predict the risk of recurrence of a NMIBCHow to tailor treatment recommendationsGuest: Prof....

Welcome to the EAU Podcast. In this episode, we have compiled some useful background information on why the EAU is branching out into podcasting, how it will engage listeners, and reach new audiences.

In this episode, we compiled tips and tricks in how to record a podcast. These will include useful information on:How to prepare for a recording (e.g. practicing your speech and using your mobile as a recording device)What to take into account during the recording processWhat to do next after recordingWe also discussed why the EAU is branching out to podcasting, how it will engage listeners, and reach new audiences.

In this first part, Prof. Nicolas Mottet talks about the most important changes in the new EAU Guidelines for Prostate Cancer treatment and discusses in more detail perineal biopsy, staging PSMA, adjuvant Radio Therapy. #prostatecancer